These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29606647)

  • 1. Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies.
    Leclair V; Labirua-Iturburu A; Lundberg IE
    J Rheumatol; 2018 Apr; 45(4):581-583. PubMed ID: 29606647
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
    Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J
    Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
    De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
    Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful lung transplant in rapid progressive interstitial lung disease associated with anti-melanoma differentiation associated gene 5.
    Huang K; Levy RD; Avina-Zubieta JA
    Rheumatology (Oxford); 2020 Aug; 59(8):2161-2163. PubMed ID: 32068868
    [No Abstract]   [Full Text] [Related]  

  • 5. Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis.
    Zhang X; Zhou S; Wu C; Li M; Wang Q; Zhao Y; Zeng X
    Rheumatology (Oxford); 2021 Jul; 60(7):e227-e228. PubMed ID: 33410494
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of simultaneous onset of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis accompanied by interstitial pneumonia and pulmonary tuberculosis.
    Fujimoto S; Saito K; Kuwano K
    Int J Rheum Dis; 2020 Feb; 23(2):273-275. PubMed ID: 31916372
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
    Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
    Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Gottron's Sign in A Patient With Anti-MDA5 Associated Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
    Lee HJ; Feng A; Huan NC
    Am J Med Sci; 2021 Oct; 362(4):e35. PubMed ID: 33582154
    [No Abstract]   [Full Text] [Related]  

  • 9. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives in the treatment of interstitial lung disease accompanied with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
    Tsuji H; Nakashima R; Mimori T
    Int J Rheum Dis; 2024 May; 27(5):e15201. PubMed ID: 38769940
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-MDA-5-positive dermatomyositis associated rapidly progressive interstitial lung disease, a virus-triggered autoimmune-like symptom?
    Xu L; Wang L; Lv C; Tan W
    Rheumatology (Oxford); 2021 Sep; 60(9):4428-4429. PubMed ID: 33752230
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.
    Yamaoka T; Doi C; Yokomi A; Tanemura A; Murota H; Tani M; Saruban H; Hamaguchi Y; Fujimoto M; Katayama I
    Eur J Dermatol; 2014; 24(4):490-1. PubMed ID: 25075604
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Diagnosis is Obvious].
    Fisser C; Wiest C; Hamer OW; Müller T; Lubnow M; Pfeifer M; Lerzer C; Dvorak I
    Pneumologie; 2020 Nov; 74(11):780-786. PubMed ID: 32663889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease.
    Witkowska AB; Cowley S; Dempsey P; Stack J
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35236677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of multi-target therapy in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with early-stage interstitial lung disease.
    Suda M; Kataoka Y; Tomishima Y; Jinta T; Rokutanda R; Kishimoto M; Okada M
    Scand J Rheumatol; 2017 Nov; 46(6):505-506. PubMed ID: 28649889
    [No Abstract]   [Full Text] [Related]  

  • 16. Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium.
    Figueiredo C; Matos AL; Calvao J; Goncalo M
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762870
    [No Abstract]   [Full Text] [Related]  

  • 17. Case of anti-MDA-5 positive dermatomyositis with rapidly progressive interstitial lung disease.
    Fenando A; Firn K; Louissa S; Hussain A
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32354766
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease.
    Miyake M; Sakai A; Nishijima C; Kita T; Nitta E; Kawashima A; Hamaguchi Y; Fujimoto M; Inaoki M
    J Dermatol; 2014 Jul; 41(7):664-5. PubMed ID: 24930560
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease.
    Fujimoto N; Honda S; Wakabayashi M; Hamaguchi Y; Fujimoto M; Tanaka T
    Mod Rheumatol; 2016 Jul; 26(4):614-6. PubMed ID: 24842478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.
    Nakashima R; Hosono Y; Mimori T
    Lupus; 2016 Jul; 25(8):925-33. PubMed ID: 27252271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.